Pfizer Wins $10 Billion Battle for Metsera After Novo Nordisk Pulls Out of Bidding War

Pfizer has clinched a $10 billion deal to acquire obesity drugmaker Metsera, defeating Novo Nordisk in a high-stakes bidding war. Metsera’s board approved Pfizer’s $86.25-per-share offer,...